代谢测试市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

代谢测试市场按产品类型(身体成分分析仪、心肺运动测试 (CPET) 系统、心电图系统、代谢推车等)、应用、最终用户和地理位置进行细分。

市场快照

Metabolic Testing Market Overview
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 7.5 %
Metabolic Testing Market Major Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

代谢率可能因人而异,取决于性别、身高、体重、年龄、肌肉与脂肪的比例以及当前的身体活动。新陈代谢分为两种类型,可分为两类分解代谢,即分解食物以获得能量和合成代谢,利用分解代谢反应产生的能量从较小的分子(如蛋白质中的氨基酸)合成较大的分子。分解代谢和合成代谢组反应对维持生命至关重要。 

根据世界卫生组织 (WHO) 的数据,超过 6.5 亿成年人肥胖,4100 万 5 岁以下儿童肥胖。根据全球疾病负担研究,约有 470 万人因肥胖而过早死亡。因此,心血管疾病、肥胖症、糖尿病、技术进步和医疗保健支出等生活方式疾病的日益流行是代谢检测市场的关键驱动因素。

报告范围

根据报告的范围,新陈代谢是在生命系统中发生的化学反应,例如在细胞、组织、器官或有机体中,为重要过程和新有机材料的合成提供能量。

By Equipment Type
Body Composition Analyzers
Cardiopulmonary Exercise Testing (CPET) Systems
ECG Systems
Metabolic Carts
Others
By Application
Critical Care
Lifestyle Diseases
By End User
Hospitals and Clinics
Sports Training Centers
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

生活方式疾病板块有望在代谢检测市场占据主要市场份额

生活方式疾病细分市场占有主要市场份额,预计在预测期内将显着增长。生活方式疾病,如动脉粥样硬化、心脏病、肥胖症和 2 型糖尿病以及与吸烟和饮酒相关的疾病。生活方式和饮食模式等因素对心脏代谢疾病和其他代谢紊乱有明显和可区分的影响。 

根据世界卫生组织 (WHO) 的数据,每年至少有 280 万人因肥胖而死亡,每年约有 1700 万人死于心血管疾病。因此,心血管疾病、糖尿病和肥胖等生活方式疾病的患病率上升是研究市场的关键驱动因素。

Metabolic Testing Market Trends

北美预计将在市场上占有重要份额,预计在预测期内也将如此

由于该地区心血管疾病、肥胖症和 2 型糖尿病等生活方式疾病的患病率上升,预计北美将在全球代谢检测市场占据主要市场份额。根据美国糖尿病协会 (ADA) 的数据,2018 年,约有 3420 万美国人或 10.5% 的人口患有糖尿病。此外,代谢检测市场采用先进技术的兴起以及完善的医疗保健设施的存在在很大程度上推动了整个区域市场的增长。

Metabolic Testing Market Growth

竞争格局

代谢测试市场适度分散,竞争激烈,由多个市场参与者组成。就市场份额而言,目前很少有主要参与者占据市场主导地位。目前主导市场的一些公司是 MGC Diagnostics Corporation、COSMED Srl、CORTEX Biophysik GmbH、通用电气公司、KORR Medical Technologies, Inc、CareFusion Corporation、Geratherm Medical AG、OSI Systems, Inc、AEI Technologies, Inc、Parvo医务人员。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Incidence of Lifestyle Diseases

      2. 4.2.2 Technological Advancements in Metabolic Testing

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Equipment and Software

      2. 4.3.2 Poor Reimbursement Policies

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Equipment Type

      1. 5.1.1 Body Composition Analyzers

      2. 5.1.2 Cardiopulmonary Exercise Testing (CPET) Systems

      3. 5.1.3 ECG Systems

      4. 5.1.4 Metabolic Carts

      5. 5.1.5 Others

    2. 5.2 By Application

      1. 5.2.1 Critical Care

      2. 5.2.2 Lifestyle Diseases

    3. 5.3 By End User

      1. 5.3.1 Hospitals and Clinics

      2. 5.3.2 Sports Training Centers

      3. 5.3.3 Others

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 MGC Diagnostics Corporation

      2. 6.1.2 COSMED srl

      3. 6.1.3 CORTEX Biophysik GmbH

      4. 6.1.4 GE Healthcare (General Electric Company)

      5. 6.1.5 KORR Medical Technologies, Inc

      6. 6.1.6 CareFusion Corporation

      7. 6.1.7 Geratherm Medical AG

      8. 6.1.8 OSI Systems, Inc

      9. 6.1.9 AEI Technologies, Inc

      10. 6.1.10 Parvo Medics

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Metabolic Testing Market market is studied from 2018 - 2026.

The Metabolic Testing Market is growing at a CAGR of 7.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

MGC Diagnostics Corporation, COSMED Srl, CORTEX Biophysik GmbH, GE Healthcare, KORR Medical Technologies, Inc are the major companies operating in Metabolic Testing Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!